1. How do advances in neuroimaging techniques, such as diffusion tensor imaging (DTI) and resting-state functional connectivity MRI (rs-fcMRI), contribute to our understanding of the neural circuitry underlying neuropsychiatric disorders, and how might this knowledge inform the development of novel targeted interventions, such as neuromodulation techniques and pharmacogenomics-based treatments ?